SEC 13F Intelligence

Point72 Middle East Fze / BIIB

Point72 Middle East Fze’s Biogen Inc Position

Does Point72 Middle East Fze own Biogen Inc (BIIB)? Not currently — the last reported position was 42.5K shares worth $12M in Q2 2023; the fund’s latest 13F (Q3 2025) no longer reports it.

Position Value
$12M
Q2 2023
Shares
42.5K
% of Portfolio
+0.34%
Quarters Held
3
position exited

Position History BIIB

Reported value by quarter
Q4 ’22: $12MQ4 ’22Q1 ’23: $2,224Q1 ’23Q2 ’23: $12MQ2 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202342.5K$12M+0.34%
Q1 20238$2,2240.00%
Q4 202242.4K$12M+0.51%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Point72 Middle East Fze’s full portfolio or all institutional holders of BIIB.